Home > Insights > Blogs > Life Sciences Decoded > "DEA"

Life Sciences Decoded

Life Sciences Decoded

(By accessing, browsing or using the pages below, you agree to the Blog Conditions of Use/Disclaimer available under "Links.")

Posts

Blog Browse: CBD drugs moved to Schedule 5; no promises for cannabis

October 1, 2018
Marijuana and cannabis oil

The DEA has moved CBD prescription drugs with THC levels below .01% to a Schedule 5 drug after the FDA’s approval of Epidolex. However, despite the reschedule, cannabis still remains a Schedule 1 substance. READ MORE